Abstract
Benign prostatic hyperplasia (BPH) is common in older men and is characterized by nonmalignant growth of the prostate gland, which can cause obstructive and irritative urinary symptoms. Currently, treatment has evolved from pharmacological options to minimally invasive surgical interventions such as transurethral resection of the prostate (TUR) and Holmium laser enucleation (HoLEP). The objective of this research is to analyze the principles of these surgical techniques and characterize their benefits and complications to facilitate decision making. An electronic search was carried out for scientific articles published from January 2019 to October 2024 in databases such as PubMed, Scopus, Web of Science and Scielo. TUR involves the removal of glandular tissue from the prostatic transition zone and is a safe procedure, considered the gold standard in treatment. For its part, HoLEP is less painful, with fewer side effects, reduction in hospital admissions and short stays, representing an economic benefit for countries with free health systems such as Ecuador. In conclusion, both TUR and HoLEP are effective and safe therapeutic alternatives for BPH, with good clinical response, with HoLEP being associated with less hospitalization; however, there are barriers such as medical costs that limit its continued use.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call